Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BMSNbroke prior resistance on 5/31. This is real upward movement.
BMSN This stock is moving because of news and prio news. This is a real company !
On May 30, 2012 Regen entered into a Letter of Intent (“LOI”) with Clinartis LLC (“Clinartis”), a contract research organization, whereby Clinartis will provide services to Regen which will include the following:
Assessment of the probability of clinical and regulatory success, and commercial potential of intellectual property;
Due diligence on published data and data supporting patent claims;
Development of the regulatory strategy for development of novel therapies;
Design and development of clinical development program for novel therapies;
Support for solicitation of FDA and other regulatory agencies feedback on the regulatory strategy and clinical development of novel therapies;
Preparation and submission of INDs, BLAs, NDAs to FDA and similar regulatory submissions in foreign jurisdictions;
Feasibility assessment for conducting clinical trial for novel therapies;
Setup, management and monitoring of clinical trials on a global basis;
Analysis of clinical data, preparation of study reports.
The LOI contemplates Regen and Clinartis entering into a Master Services Agreement which shall outline the general terms for providing services by Clinartis.
BMSN[/b. If it breaks .0039, there will be no resistance. Get in before this happens !! BIG news out now ! The LOI will bring big things to this company. This stock is way oversold and undervalued.
BMSN[/b. If it breaks .0039, there will be no resistance. Get in before this happens !!
BMSN[/b. If it breaks .0039, there will be no resistance. Get in before this happens !!
BMSN Why it is running explained.
On May 30, 2012 Regen entered into a Letter of Intent (“LOI”) with Clinartis LLC (“Clinartis”), a contract research organization, whereby Clinartis will provide services to Regen which will include the following:
-
Assessment of the probability of clinical and regulatory success, and commercial potential of intellectual property;
-
Due diligence on published data and data supporting patent claims;
-
Development of the regulatory strategy for development of novel therapies;
-
Design and development of clinical development program for novel therapies;
-
Support for solicitation of FDA and other regulatory agencies feedback on the regulatory strategy and clinical development of novel therapies;
-
Preparation and submission of INDs, BLAs, NDAs to FDA and similar regulatory submissions in foreign jurisdictions;
-
Feasibility assessment for conducting clinical trial for novel therapies;
-
Setup, management and monitoring of clinical trials on a global basis;
-
Analysis of clinical data, preparation of study reports.
The LOI contemplates Regen and Clinartis entering into a Master Services Agreement which shall outline the general terms for providing services by Clinartis.
BMSN Why it is running explained.
On May 30, 2012 Regen entered into a Letter of Intent (“LOI”) with Clinartis LLC (“Clinartis”), a contract research organization, whereby Clinartis will provide services to Regen which will include the following:
-
Assessment of the probability of clinical and regulatory success, and commercial potential of intellectual property;
-
Due diligence on published data and data supporting patent claims;
-
Development of the regulatory strategy for development of novel therapies;
-
Design and development of clinical development program for novel therapies;
-
Support for solicitation of FDA and other regulatory agencies feedback on the regulatory strategy and clinical development of novel therapies;
-
Preparation and submission of INDs, BLAs, NDAs to FDA and similar regulatory submissions in foreign jurisdictions;
-
Feasibility assessment for conducting clinical trial for novel therapies;
-
Setup, management and monitoring of clinical trials on a global basis;
-
Analysis of clinical data, preparation of study reports.
The LOI contemplates Regen and Clinartis entering into a Master Services Agreement which shall outline the general terms for providing services by Clinartis.
BMSN on its way to break with new HOD .0037 ! Get in while you can.
BMSN on its way to break HOD ! Get in while you can.
BMSN on its way to break HOD ! Get in while you can.
BMSN has news, this thing moves easy. Get in before it goes up. Very oversold right now.
imo. GL
BMSN has news, this thing moves easy. Get in before it goes up. Very oversold right now.
imo. GL
LOL, that promo is doing nothing for this stock, continues to go lower.
If this dont bounce off the .0021, this stock is dead !
We hit .0028, .0022 may be next if news does not come out soon.
This stock is slowly going down. .006 to .0035 in 2 days wow..
Yeah, its set to close well EOD.
Chart shows CYNX making a move to higher levels shortly. Hopefully charts proves to be right.
IMO
just need to break .0094
ECDC Lift Off !
If you say so heh. Penny Charts are mostly driven on news. But you still have to pay attention to technical indicators as well. Charts show more than just ut and dt.
Charts indicate downtrend
I have a Scottrade account and my account shows no signs of a reverse split. I do not own a large position in ACLH, but I do own a decent amount of shares. I am not selling and am waiting for Monday to see what happens. There will be a gap up Monday and then it may lower some, or a sell off early Monday morning and then a gap up IMO. Either way, I am staying in this stock firmly. There is an a oil spill, and someone has to clean it. A common sense stock, but still be careful IMO. I believe ACLH and MOPN will get the most play. GL